A healthcare provider may prescribe Restasis for treating dry eyes. This medication is specifically designed for people who have chronic dry eyes and have reduced tear production due to inflammation. It comes in the form of an eye drop and is typically used twice daily. Possible side effects may include burning, itching, redness, or stinging.
What Is Restasis?
Restasis® (cyclosporine ophthalmic emulsion) is a prescription eye drop used to treat chronic dry eyes (known medically as keratoconjunctivitis sicca). This medicine increases the amount of tears in your eyes when tear production is reduced due to inflammation.
(Click Restasis Uses for more information on what the medication is used for, including possible off-label uses.)
Who Makes This Medication?
Restasis is made by Allergan, Inc.
How Does Restasis Work?
There are many potential causes of dry eyes. Sometimes, people with dry eyes have inflammation, or swelling, of the eyes. This inflammation can interfere with the eyes' ability to produce tears. As a result, fewer tears are produced, and the eyes become dry.
Restasis belongs to a group of medications known as immunosuppressants, which work by decreasing the activity of the immune system. It is thought that Restasis works by deceasing eye inflammation and increasing tear production.
Micromedex Healthcare Series [Internet database]. Greenwood Village, Colo: Thomson Reuters (Healthcare), Inc. Updated periodically. Accessed August 4, 2009.
National Library of Medicine (US). Hazardous Substances Data Bank (HSDB). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB. Accessed August 4, 2010.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2008.
National Library of Medicine (US). Drugs and Lactation Database (LactMED). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT. Accessed April 21, 2010.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed August 3, 2010.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click